Serum Levels of Chemokines in Parkinson’s Disease

Inflammation and Parkinson's disease pathogenesis

(2010) Serge Przedborski   MOVEMENT DISORDERS

Neuroinflammation in Parkinson’s Disease

(2009) Jae-Kyung Lee et al.   Journal of Neuroimmune Pharmacology

Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's disease

(2009) Paula Scalzo et al.   JOURNAL OF NEUROIMMUNOLOGY

Cerebrospinal fluid levels of chemokines in HIV infected patients with and without opportunistic infection of the central nervous system

(2009) Paulo Pereira Christo et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

(2009) Etienne C Hirsch et al.   LANCET NEUROLOGY

Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance

(2009) Paula Scalzo et al.   NEUROSCIENCE LETTERS

CXCR4 and CXCL12 Expression is Increased in the Nigro-Striatal System of Parkinson’s Disease

(2009) Mika Shimoji et al.   NEUROTOXICITY RESEARCH

Peripheral cytokines profile in Parkinson’s disease

(2008) M. Reale et al.   BRAIN BEHAVIOR AND IMMUNITY

The α-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease

(2008) Patrick L. McGeer et al.   EXPERIMENTAL NEUROLOGY

Glial Cells as Players in Parkinsonism: The “Good,” the “Bad,” and the “Mysterious” Glia

(2008) Maria A. Mena et al.   NEUROSCIENTIST

Inflammation as a causative factor in the aetiology of Parkinson's disease

(2007) P S Whitton   BRITISH JOURNAL OF PHARMACOLOGY